Skip to main content
SpringerLink
Log in

Knowledge of HIV serostatus and preventive behaviour among European injecting drug users: Second study

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

The objective of the study was to analyse the effect of knowledge of HIV serostatus on behaviours preventing the acquisition or transmission of HIV among European IDU, and to compare results with a previous similar study conducted 3 years before. Data were gathered in 1992–1993 during a retrospective multicentre cross-sectional study of IDU recruited in 11 European countries, in specialized centers and on the street. We compared, between groups with different HIV serological status (IDU who knew well before their HIV-positive serological status, IDU who knew their HIV-negative serostatus and IDU who did not know before their serological status), the respective proportions of IDU who reported that, during the six months prior to interview, (1) always used condoms, (2) never gave their used injecting equipment to other IDU, (3) always injected drugs safely. We only included IDU who had known their serological status for at least six months prior to interview. Results were compared to the similar survey conducted in 1990. From 2171 IDU recruited, data of 1334 IDU were included in the analysis. Compared with IDU who did not know their HIV serostatus, only IDU knowing their HIV-positive serostatus used condoms significantly more often (37% compared to 15%, rate ratio (RR): 2.4; 95% confidence interval (CI): 1.8–2.3) and never gave their used injecting equipment to other IDU (69% compared to 53%, RR: 1.3; 95% CI: 1.2–1.4). In comparison with the 1990 study, only condom use significantly improved and only for IDU who knew their HIV-negative serostatus (13% compared to 9%, RR: 1.6; 95% CI: 1.1–2.3). This study confirms among European IDU the relation between knowing own HIV serological status to preventive behaviours. However, there were only minor improvements between 1990 and 1992–1993, indicating that prevention of HIV transmission among IDU must be reinforced.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Public Health Services. Guidelines for counseling and antibody testing to prevent HIV infection and AIDS. MMWR 1987; 36: 509–515.

    Google Scholar 

  2. Brickner PW, Torres RA, Barnes M, et al. Recommendations for control and prevention of human immunodeficiency virus in intravenous drug users. Ann Intern Med 1989; 110: 833–837.

    Google Scholar 

  3. Hinman AR. Strategies to prevent HIV infection in United States. Am J Public Health 1991; 81: 1557–1558.

    Google Scholar 

  4. Higgins DL, Galavotti C, O'Reilly KR, et al. Evidence for the effects of HIV antibody counseling and testing on risk behaviors. JAMA 1991; 266: 2419–2429.

    Google Scholar 

  5. Fox R, Odaka NJ, Brookmayer R, Polk BF. Effect of HIV-antibody disclosure on subsequent sexual activity in homosexual men. AIDS 1987; 1: 241–246.

    Google Scholar 

  6. McCusker J, Stoddard AM, Mayer KH, Zapka J, Morrison-Saltzman SP. Effects of antibody testing test knowledge on subsequent sexual behavior in a cohort of homosexually active men. Am J Public Health 1988; 78: 462–467.

    Google Scholar 

  7. Zones JS, Beeson D, Echenberg DF, Frigo MA, O'Malley PM, Rutherford GW. Personal and social consequences of AIDS antibody testing and notification in a cohort of homosexual and bisexual men. II International Conference on AIDS, Paris, June 1986 (abstract 445).

  8. Valdiserri RO, Lyter DI, Leviton LC, Callahan CM, Kingsley LA, Rinaldo CR. Variables influencing condom use in a cohort of homosexual and bisexual men. Am J Public Health 1988; 78: 801–805.

    Google Scholar 

  9. Frazer IH, McCamish M, Hay I, North P. Influence of Human Immunodeficiency Virus antibody testing on sexual behaviour in a ‘high risk’ population from a ‘low risk’ city. Med J Aust 1988; 149: 365–368.

    Google Scholar 

  10. Ross MW. Relationship of combination of AIDS counseling and testing to safer test and condom use in homosexual men. Community Health Stud 1988; 12: 322–327.

    Google Scholar 

  11. Ostrow DG, Joseph JG, Kessler R, et al. Disclosure of HIV-antibody status: Behavioral and mental health correlates. AIDS Educ Prev 1989; 1: 1–11.

    Google Scholar 

  12. Doll LS, O'Malley P, Pershing A, Darrow WW, Hessol N, Lifson A. High risk sexual behavior and knowledge of HIV-antibody status in the San Francisco city clinic cohort. Health Psychol 1990; 9: 253–265.

    Google Scholar 

  13. Hamers FF, Batter V, Downs AM, Alix J, Cazein F, Brunet JB. The HIV epidemic associated with injecting drug use in Europe: Geographic and time trends. AIDS 1997; 11: 1365–1374.

    Google Scholar 

  14. Marlink RG, Foss B, Swift R, et al. High rate of HTLV III/HIV exposure in IVDU from a small-size city and the failure of a specialized methadone maintenance to prevent further drug use. III International Conference on AIDS, Washington DC, June 1987 (abstract TH51).

  15. Power R, Hartnoll R, Daviaud E. Drug injecting, AIDS and risk behaviour: Potential for change and intervention strategies. Br J Addict 1988; 88: 649–654.

    Google Scholar 

  16. Calsyn DA, Saxon A, Freeman G, Whittaker S. Ineffectiveness of AIDS education and HIV-antibody testing in reducing high-risk behaviors among injecting drug users. Am J Public Health 1992; 82: 573–575.

    Google Scholar 

  17. Keffelew A, Baccheti CC, Gorter R, Osmond CR, Moss AR. Use of needle-exchange programs by San Francisco drug users in methadone treatment. IV International Conference on AIDS. San Francisco, June 1990 (abstract FC 105).

  18. Van den Hoek JAR, van Haastrecht HJA, Coutinho RA. Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS. Am J Public Health 1989; 79: 1355–1357.

    Google Scholar 

  19. Van den Hoek JAR, van Haastrecht HJA, Coutinho RA. Little change in sexual behaviour in injecting drug users in Amsterdam. J Acquir Immune Defic Syndr 1992; 5: 518–522.

    Google Scholar 

  20. Casadonte PP, des Jarlais DC, Friedman SR, Rotrosen JP. Psychological and behavioral impact among intravenous drug users of learning HIV test results. Int J Addict 1990; 25: 409–426.

    Google Scholar 

  21. Van den Hoek JAR, van Haastrecht JA, Coutinho RA. Heterosexual behaviour of intravenous drug users in Amsterdam: Implication for the AIDS epidemic. AIDS 1990; 4: 449–453.

    Google Scholar 

  22. Farley T, Carter M, Hadler J. HIV counseling and testing in methadone programs: Effect of treatment compliance. IV International Conference on AIDS, San Francisco, June 1990 (abstract SC660).

  23. Skidmore CA, Robertson JR, Roberts JJK. Changes in HIV risk-behaviours in intravenous drug users: A second follow-up. Br J Addict 1989; 84: 685–695.

    Google Scholar 

  24. Robertson JR, Skidmore CA, Roberts JJK. HIV infection in intravenous drug users: A second follow-up. Br J Addict 1989; 84: 695–696.

    Google Scholar 

  25. Gibson DR, McCusker J, Chesney M. Effectiveness of psychosocial interventions in preventing HIV risk behavior in injecting drug users. AIDS 1998; 12: 919–929.

    Google Scholar 

  26. Roggenburg L, Sibthorpe B, Tessalar H, Gould J, Flemming D. Characteristics of IVDUs who have been HIV tested. IV International Conference on AIDS, San Francisco, June 1990 (abstract SC662).

  27. Desenclos JC, Papaevangelou G, Ancelle-Park R, et al. Knowledge of HIV serostatus and preventive behaviour among European injecting drug users. AIDS 1993; 7: 1371–1373.

    Google Scholar 

  28. Richardson SC, Papaevangelou G, Ancelle-Park R. Knowledge, attitudes and beliefs of European injecting drug users concerning preventive measures for HIV. Eur J Epid 1994; 10: 135–142.

    Google Scholar 

  29. Richardson SC, Ancelle-Park R, Papaevangelou G. Factors associated with HIV seropositivity in European injecting drug users. AIDS 1993; 7: 1485–1491.

    Google Scholar 

  30. Sudman S, Kalton G. New developments in the sampling of special populations. Ann Rev Sociol 1986; 12: 401–429.

    Google Scholar 

  31. Mickeyl RM, Greenland S. The impact on confounder selection on effect modification. Am J Epidemiol 1989; 129: 125–137.

    Google Scholar 

  32. Dean AD, Dean JA, Burton JH, Dicker RC. Epi Info, version 5.1: A word processing Database and statistics Program for Epidemiology and Microcomputers. Georgia: Centers for Disease Control, 1991.

    Google Scholar 

  33. Greenland S, Robins JM. Estimation of a common effect parameter from sparse follow-up data. Biometrics 1985; 41: 55–68.

    Google Scholar 

  34. Delgado-Rodriguez M, de la Fuente L, Bravo MJ, Lardelli P, Barrio G. IV drug users: Changes in risk behaviour according to HIV status in a national survey in Spain. J Epidemiol Community Health 1994; 48: 459–463.

    Google Scholar 

  35. Peters AD, Reid MM, Griffin SG. Edinburgh drug users; are they injecting and sharing less? AIDS 1994; 8: 459–463.

    Google Scholar 

  36. Hull HF, Bettinger CJ, Gallagher MM, et al. Comparison of HIV-antibody prevalence in patients consenting to and declining HIV-antibody testing in STD clinic. JAMA 1988; 7: 953–958.

    Google Scholar 

  37. Rearson J, Warren N, Keilch R, Dale J, Wise F, Brunner W. Are HIV-infected drug users taking HIV test? Am J Public Health 1993; 10: 1414–1417.

    Google Scholar 

  38. McElrath K, Chitwood DD, Grifin DK, Comerford M. The consistency of self-reported HIV risk behavior among Injecting Drug Users. Am J Public Health 1994; 84: 1965–1970.

    Google Scholar 

  39. Latkin CA, Vlahov D, Anthony JC. Socially desirable responding in self-reported drug users. Addiction 1993; 88: 517–526.

    Google Scholar 

  40. Booth E, Watters JK. How effective are risk-reduction interventions targeting injecting drug users? AIDS 1994; 8: 1515–1524.

    Google Scholar 

  41. Van Ameijdan EJC, Watters JK, van den Hoek JAR, Coutinho RA. Interventions among injecting drug users: Do they work? AIDS 1995; 9: S75-S84.

    Google Scholar 

  42. Papaevangelou G, Coutinho R, Ancelle-Park R, Richardson SC. HIV prevalence and risk factors among IDU in EC countries and COST countries. (Final report). Athens, December 1993, 49 pp.

  43. Des Jarlais DC, Friedman SR, Sotheran SR, et al. Continuity and change within an HIV epidemic, injecting drug users in New York City, 1984 through 1992. JAMA 1994; 271: 121–127.

    Google Scholar 

  44. Siddiqui SN, Brown LS, Phillips RY, Vargas O, Makuch RW. No seroconversion among steady sex partners of methadone-maintained HIV-1 seropositive injecting drug users in New York city. AIDS 1992; 6: 1529–1533.

    Google Scholar 

  45. De Vincenzi et al. A longitudinal study of Human Immunodeficiency Virus transmission by heterosexual partners. N Eng J Med 1994; 6: 341–346.

    Google Scholar 

  46. Van den Hoek JAR, Coutinho RA, van Haastrecht HJA, van Zadelhoff AW, Goudsmit J. Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam. AIDS 1988; 2: 55–60.

    Google Scholar 

  47. Van Ameijden EJC, van den Hoek JAR, Coutinho RA. Large declines in sexual risk behaviour with noncommercial partners among heterosexual injection drug users in Amsterdam, 1989–1995. Am J Epidemiol 1996; 8: 772–781.

    Google Scholar 

  48. Van Ameijden EJC, van den Hoek JAR, van Haastrecht HJA, Coutinho RA. The arm reduction approach and risk factors for Human Immunodeficiency Virus (HIV) seronconversion in injecting drug users, Amsterdam. Am J Epidemiol 1992; 136: 236–243.

    Google Scholar 

  49. Diaz T, Chu SY, Weinstein B, Mokotoff E, Jones TS. Injection and syringe sharing among HIV-infected injection drug users: Implications for prevention of HIV transmission. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18Suppl 1: S76-S81.

    Google Scholar 

  50. Weber U, Schneider W. Syringe exchange in Germany. Subst Use Misuse 1998; 33,5: 1093–1112.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Réseau National de Santé Publique, Hôpital National de Saint-Maurice, France

    Martin G. Schlumberger & Jean-Claude Desenclos

  2. European Center for the Epidemiological Monitoring of AIDS, Hôpital National de Saint-Maurice, France

    Rosemary Ancelle-Park

  3. Association pour l'aide à la Médecine Préventive, France

    Martin G. Schlumberger

  4. National School of Public Health, Greece

    George Papaevangelou

  5. Panteion University of Social and Political Sciences, Athens, Greece

    S. Clive Richardson

Authors
  1. Martin G. Schlumberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jean-Claude Desenclos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. George Papaevangelou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Clive Richardson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rosemary Ancelle-Park
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schlumberger, M.G., Desenclos, JC., Papaevangelou, G. et al. Knowledge of HIV serostatus and preventive behaviour among European injecting drug users: Second study. Eur J Epidemiol 15, 207–215 (1999). https://doi.org/10.1023/A:1007578402083

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007578402083

Search

Navigation